Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy
between this translated document and the Japanese original, the original shall prevail.

October 31, 2023

Consolidated Financial Results
for the Six Months Ended September 30, 2023
(Under Japanese GAAP)
Company name: Taoka Chemical Co., Ltd
Listing:
Tokyo Stock Exchange
Securities code: 4113
URL:
https://www.taoka-chem.co.jp
Representative: Yasuaki Sasaki, President
Inquiries:
Yasuhito Katsumoto, General Manager, Business Services OfficeTelephone:+81-6-7639-7400
Scheduled date to file quarterly securities report:
November 10, 2023
Scheduled date to commence dividend payments:
December 4, 2023
Preparation of supplementary material on quarterly financial results: None
Holding of quarterly financial results briefing: Yes (for institutional investors and analysts)(Yen amounts are rounded down to millions, unless otherwise noted.)

1. Consolidated financial results for the six months ended September 30, 2023 (from April 1,
2023 to September 30, 2023)(1) Consolidated operating results (cumulative)
Sales revenue
Six months ended

Millions ofyen%

14,811
15,264(3.0)(9.4)

September 30, 2023
September 30, 2022
Note: Comprehensive income(Percentages indicate year-on-year changes.)

Operating income

Ordinary income

Net income
attributable toowners of theparent

Millions ofyen

Millions ofyen

Millions ofyen%

573 130.1
249 (86.4)%

620 121.9
279 (85.0)

459 140.4
191 (85.7)

For the six months ended September 30, 2023: ¥496 million [106.1%]
For the six months ended September 30, 2022: ¥240 million [(81.9)%]

Net income
per share

Diluted net income
per share

Six months ended
September 30, 2023

Yen

Yen

32.09

－

September 30, 2022

13.35－%

(2) Consolidated financial position

As ofSeptember 30, 2023
March 31, 2023

Equity-to-asset
ratio

Total assets

Net assets

Millions of yen

Millions of yen%

30,31531,06916,938
16,57055.9
53.3

Reference: Equity
As of September 30, 2023:
As of March 31, 2023:¥16,938 million¥16,570 million

2. Cash dividends
Annual dividends per share
SecondThird
Fiscal yearquarter-end
quarter-end
endFirstquarter-end
Fiscal year ended
March 31, 2023Fiscal year ending
March 31, 2024
Fiscal year ending
March 31, 2024(Forecast)

Total

Yen

Yen

Yen

Yen

Yen－

18.00

－

9.00

27.00

－

9.00
－

9.00

18.00

Note: Revisions to the forecasts of cash dividends most recently announced: None

3. Consolidated financial forecasts for the fiscal year ending March 31, 2024 (from April 1,2023 to March 31, 2024)(Percentages indicate year-on-year changes.)

Operating income Ordinary income

Net income
attributable toowners of theparent%

Millions ofyen%%Millions ofyen%yen

28,000 (7.2)

70055.2700 52.9

40028.8

27.92

Sales revenue
Millions ofyen

Full year

Millions ofyenNet
incomeper share

Note: Revisions to the forecasts of consolidated financial results most recently announced: Yes
For details of the revisions of consolidated financial results forecasts, please refer to “Differences
between Financial Forecasts and Actual Results for Six-Months Ended September 30, 2023, andRevisions to Full-Year Financial Forecasts,” disclosed on October 31, 2023.

* Notes(1) Changes in significant subsidiaries during the period (changes in specified subsidiaries resultingin the change in scope of consolidation): None
(2) Adoption of accounting treatment specific to the preparation of quarterly consolidated financialstatements: Yes(3) Changes in accounting policies, changes in accounting estimates, and restatement(i) Changes in accounting policies due to revisions to accounting standards and otherregulations: None(ii) Changes in accounting policies due to other reasons: None(iii) Changes in accounting estimates: None(iv) Restatement: None
(4) Number of issued shares (common shares)(i) Total number of issued shares at the end of the period (including treasury shares)
As of September 30, 2023
As of March 31, 2023

14,440,000 shares
14,440,000 shares(ii) Number of treasury shares at the end of the period
As of September 30, 2023
As of March 31, 2023

111,140 shares
111,140 shares(iii) Average number of shares outstanding during the period (cumulative from the beginning ofthe fiscal year)
Six months ended September 30, 2023
Six months ended September 30, 2022

14,328,860 shares
14,328,860 shares* Quarterly financial results reports are exempt from quarterly review conducted by certified public
accountants or an audit corporation.
* Proper use of earnings forecasts, and other special matters(Caution regarding forward-looking statements and others)
The forward-looking statements, including financial forecasts, contained in this report are based on
information currently available to the Company and certain assumptions deemed to be reasonable.
Accordingly, they are not intended to be construed as assurance that they will be accomplished in
the future. Note that actual results may differ materially from the forecasts for a number of reasons.

The Taoka Chemical Group’s consolidated sales revenue for the six months ended September 30,2023, decreased by ¥ 452 million compared with the same period of the previous fiscal year, to¥14,811 million. The Group posted operating income of ¥ 573 million, ordinary income of ¥ 620
million and net income attributable to owners of the parent of ¥ 459 million.
The financial results of Taoka Chemical by business segment for the six-month period were as
follows:
Division

Six Months Ended Six Months Ended
September 30, 2022 September 30, 2023

ChangeMillions of Composition Millions of Composition Millions of Year-on-year
yenratio (%)
yenratio (%)
yenrate (%)

Fine Chemicals

7,343

48.1

7,249

48.9(94)(1.3)

Functional Chemicals
Functional Polymers andAdditives
Chemicals Segment

1,638

10.7

1,687

11.4

49

3.0

5,981

39.2

5,585

37.7(396)(6.6)

14,96398.0

14,52298.0(441)

(2.9)

300

2.0

289

2.0(10)(3.6)

15,264100.0

14,811100.0(452)(3.0)

Analytical Services
Total

Note: The “Analytical Services,” which previously composed the “Others” segment, has been presented as areportable segment because its quantitative importance has increased.

Chemicals Segment
Sales revenue of this segment was ¥14,522 million, a ¥441 million decrease compared to the same
period of the previous fiscal year.
Fine Chemicals Division
Though shipments of agrochemical intermediates increased, shipments of monomers for opticalresins decreased. As a result, the division sales revenue decreased by ¥94 million, to ¥7,249 million.
Functional Chemicals Division
Shipments of adhesives increased. As a result, the division sales revenue increased by ¥49 million
to ¥1,687 million.
Functional Polymers and Additives Division
Shipments of plasticizers decreased and sales prices of varnish decreased reflecting a decline inraw material prices. As a result, the division sales revenue decreased by ¥396 million, to ¥5,585
million.
Analytical Services Segment
Though sales of measurement and evaluation for working environment increased, sales ofcomposition and structural analysis and those of asbestos analysis decreased. As a result, the segment
sales revenue decreased by ¥10 million, to ¥289 million.